 |
|
| ICRP PUBLICATION 62: RADIOLOGICAL PROTECTION IN BIOMEDICAL RESEARCH, 62
| |
| | |
|
|
 Annals of the ICRP Volume 22/3
Annals of the ICRP Vol. 22/3
To order this title, and for more information, click here
A Report of Committee 3 adopted by the International Commission on Radiological Protection
By
. International Commission on Radiological Protection
Included in series
International Commission on Radiological Protection, 62
Description
In recent years much progress has been made in radiological methods, in dosimetry, and in the knowledge of radiation effects. The ICRP
has increased its risk estimates, and in addition, more extensive information has become available on the effect of age at exposure,
on gender differences, on the magnitude of risk and on the consequences on in utero irradiation. It is therefore timely to review
the risks and benefits of research involving the exposure of humans to radiation. The objective of Radiological Protection in Biomedical
Research is to provide advice to individuals planning such research, those involved in issuing general rules of conduct, and those
engaged in evaluation of specific research projects. The report should also be made available to those who may become the subject of
investigations (patients, volunteers). Published with this report is Addendum 1 to ICRP Publication 53, Radiation Dose to Patients
from Radiopharmaceuticals. Published in 1987, ICRP Publication 53 contained calculations on absorbed doses per unit activity
administered for some 120 radiopharmaceuticals in regular use at the time. The calculations were based upon biokinetic models and best
estimates of biokinetic data for individual radiopharmaceuticals. Since 1987 new radiopharmaceuticals have been introduced into regular
use. This addendum presents biokinetic and dosimetic data on six new radiopharmaceutics, and is intended to be part of a continuing process
of updating. Finally, a Summary of the Current ICRP Principles for Protection of the Patient in Diagnostic Radiology is included
with the report. This has been prepared to encourage medical professionals to become aware of and to utilise those basic principles,
and is an update of a previous summary that appeared in ICRP Publication 57 (1989).
Audience
For regulatory and advisory agencies at regional, national and international levels; management bodies with responsibilities for radiological
protection, professional staff used as advisors; and individuals such as radiologists who have to make decisions about the use of ionizing
radiation.
Contents
Radiological Protection in Biomedical Research. Section headings:
Introduction. Ethical aspects. The nature, types and magnitude
of radiation risks. Methodology of risk assessment - the required information. Principles of research design involving use of ionising
radiation. Factors related to project evaluation. Recommended procedures for project evaluation and responsibilities. References.
Addendum
to ICRP Publication 53. Section headings:
Introduction. Biokinetic models, absorbed doses and effective dose for individual radiopharmaceuticals.
Effective doses per unit administered activity for those radiopharmaceuticals published in ICRP Publication 53.
Summary of
the Current ICRP Principles for Protection of the Patient in Diagnostic Radiology. Section headings:
The ICRP system of radiological
protection. Health effects of ionising radiation. Radiation dose from diagnostic radiology. Absorbed dose in body tissues. Responsibilities
of the physician and role of the radiographer. X-ray examinations directly associated with illness. X-ray examinations of women. X-ray
examinations not directly associated with illness. X-ray examinations for occupational, medico-legal or insurance purposes. X-ray examinations
in medical research. Avoidance of unnecessary dose. Specific x-ray examinations.
Bibliographic & ordering Information
Paperback, publication date: MAY-1993
ISBN-13: 978-0-08-042203-9
ISBN-10: 0-08-042203-9
Imprint: PERGAMON
063/663
Last update: 4 Jul 2008
|
|
| |
| | |
|
|
| |
